These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 38910661)

  • 21. Histopathological prognosticators and their clinicopathological correlation in oral squamous cell carcinomas of the tongue.
    Pallavi K; Tandon A; Gulati N; Juneja S; Shetty DC
    J Cancer Res Ther; 2022 Dec; 18(Supplement):S226-S232. PubMed ID: 36510969
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of Matrix Metalloproteinase 9 in Predicting Lymph Node Metastases in Oral Squamous Cell Carcinoma.
    Chakraborty S; Suresh TNR; Mohiyuddin AS
    Cureus; 2023 Jan; 15(1):e33495. PubMed ID: 36756017
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of Yes-associated Protein in Oral Squamous Cell Carcinoma.
    Shelke P; Sarode GS; Sarode SC; Maniyar N; Prajapati G; Patil S
    J Contemp Dent Pract; 2019 Aug; 20(8):887-892. PubMed ID: 31797842
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New Histopathologic Risk Model for Early T-stage Oral Squamous Cell Carcinoma: Focusing on a Modified Worst Pattern of Invasion System and a New Tumor Budding Score.
    Chang HY; Hang JF; Kuo YJ
    Am J Surg Pathol; 2024 Jan; 48(1):59-69. PubMed ID: 37779502
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Elucidating the immunohistochemistry of Nanog: A transcription marker in the oral squamous cell carcinoma with emphasis on its origin as embryonic stem cell.
    Afroze SN; Rao GV; Suri S
    J Oral Maxillofac Pathol; 2022; 26(4):476-482. PubMed ID: 37082043
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Emerging histopathological parameters in the prognosis of oral squamous cell carcinomas.
    de Morais EF; Almangush A; Salo T; da Silva SD; Kujan O; Coletta RD
    Histol Histopathol; 2024 Jan; 39(1):1-12. PubMed ID: 37310089
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oral squamous cell carcinoma in the background of oral submucous fibrosis is a distinct clinicopathological entity with better prognosis.
    Gadbail AR; Chaudhary M; Gawande M; Hande A; Sarode S; Tekade SA; Korde S; Zade P; Bhowate R; Borle R; Patil S
    J Oral Pathol Med; 2017 Jul; 46(6):448-453. PubMed ID: 28129456
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Upregulation of miRNA-196a and miRNA-196b correlates with Bryne's prognostic score in oral squamous cell carcinoma.
    Singh K; Urs AB; Koner BC; Augustine J; Shrivastava R; Narayan B
    Pathol Res Pract; 2024 Jan; 253():154954. PubMed ID: 38039741
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of hyaluronan mediated motility receptor gene in oral squamous cell carcinoma and clinical prognosis.
    Tang Y; Xiao Y; Liao R
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2021 Dec; 46(12):1315-1324. PubMed ID: 35232899
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The ability of the eighth edition of the TNM staging system plus minor invasion criteria to predict the biological behaviour of oral cavity carcinomas.
    Perlangeli G; Lilloni G; Salti G; Ferri A; Ferrari S; Poli T
    J Oral Pathol Med; 2023 Sep; 52(8):746-750. PubMed ID: 37528561
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Exploring the combination of tumor-stroma ratio, tumor-infiltrating lymphocytes, and tumor budding with WHO histopathological grading on early-stage oral squamous cell carcinoma prognosis.
    Silva GVD; da Silva Dolens E; Paranaíba LMR; Ayroza ALC; Gurgel Rocha CA; Almangush A; Salo T; Brennan PA; Coletta RD
    J Oral Pathol Med; 2023 May; 52(5):402-409. PubMed ID: 36149755
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Controversies in the treatment of early-stage oral squamous cell carcinoma.
    Ferrari L; Cariati P; Zubiate I; Martínez-Sahuquillo Rico Á; Arroyo Rodriguez S; Pulgar Encinas RM; Ferrari S; Martínez Lara I
    Curr Probl Cancer; 2024 Feb; 48():101056. PubMed ID: 38096653
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessing extent of single stranded DNA damage in oral mucosal cells of patients with oral squamous cell carcinoma and its correlation with TNM staging.
    Bhagwath SS; Chandra L
    Indian J Dent Res; 2014; 25(5):555-8. PubMed ID: 25511050
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Survival and clinicopathological characteristics of different histological grades of oral cavity squamous cell carcinoma: A single-center retrospective study.
    Lin NC; Hsu JT; Tsai KY
    PLoS One; 2020; 15(8):e0238103. PubMed ID: 32841288
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of a New Outcome Prediction Model in Early-stage Squamous Cell Carcinoma of the Oral Cavity Based on Histopathologic Parameters With Multivariate Analysis: The Aditi-Nuzhat Lymph-node Prediction Score (ANLPS) System.
    Arora A; Husain N; Bansal A; Neyaz A; Jaiswal R; Jain K; Chaturvedi A; Anand N; Malhotra K; Shukla S
    Am J Surg Pathol; 2017 Jul; 41(7):950-960. PubMed ID: 28346327
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic evaluation of tumour budding in oral squamous cell carcinoma: Evidenced by CD44 expression as a cancer stem cell marker.
    Niranjan KC; Raj M; Hallikeri K
    Pathol Res Pract; 2023 Nov; 251():154883. PubMed ID: 37898041
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Histopathological assessment of tumour regression, nodal stage and status of resection margins determines prognosis in patients with oral squamous cell carcinoma treated with neoadjuvant radiochemotherapy.
    Wedemeyer I; Kreppel M; Scheer M; Zöller JE; Büttner R; Drebber U
    Oral Dis; 2014 Apr; 20(3):e81-9. PubMed ID: 23746299
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparing prognostic utility between the 8th edition of TNM staging system and the lymph node ratio for oral squamous cell carcinoma.
    Beltramini GA; Belloni LM; Fusco N; Sacconi A; Muti P; Baj A; Bolzoni AR; Giannì AB
    Head Neck; 2021 Oct; 43(10):2876-2882. PubMed ID: 34115912
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quality of Life Assessment With European Organisation for Research and Treatment of Cancer Questionnaire (Head and Neck Module 43) and Its Clinicopathological Correlation Among Patients Treated for Oral Squamous Cell Carcinoma: An Exploratory Study.
    Ramalingam K; Krishnan M; Ramani P; Muthukrishnan A
    Cureus; 2023 Feb; 15(2):e34650. PubMed ID: 36895543
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of immunomorphological patterns of cervical lymph nodes in oral squamous cell carcinoma.
    Balla H; Uppala D; Majumdar S; Kotina S; Kodati S; Namana M
    J Oral Maxillofac Pathol; 2020; 24(2):285-292. PubMed ID: 33456238
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.